Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
A series of novel N9-heterobivalent β-carbolines has been synthesized. All the novel compounds were tested for their anticancer activity against six tumour cell lines in vitro. Among these molecules, compounds 5b, and 5w exhibited strong cytotoxic activities with IC50 value of lower than 20 μM. Acut...
Main Authors: | Liang Guo, Qin Ma, Wei Chen, Wenxi Fan, Jie Zhang, Bin Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2018.1497619 |
Similar Items
-
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
by: Benedikt Judmann, et al.
Published: (2020-07-01) -
β-Carbolines in Experiments on Laboratory Animals
by: Renata Zawirska-Wojtasiak, et al.
Published: (2020-07-01) -
Recent Advances in the Synthesis of β-Carboline Alkaloids
by: Tímea Szabó, et al.
Published: (2021-01-01) -
Discovery and structure-activity relationship studies of novel tetrahydro-β-carboline derivatives as apoptosis initiators for treating bacterial infections
by: Shanshan Su, et al.
Published: (2024-04-01) -
The β-carboline analogs as a potent inhibitor for Alzheimer’s Disease, molecular docking and dynamics simulation study
by: Muhammad Taha, et al.
Published: (2023-12-01)